A molecular signature of Rb loss of function (Rbsig) consisting of 87 E2F regulated genes has been developed using palbociclib-resistant breast cancer cell models and shown to be prognostic in patients with ER+ early breast cancer [16]. This evidence concerns the gene RB1 and breast carcinoma.